Search Results - Jason C. Rech
- Showing 1 - 2 results of 2
-
1
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X<sub>7</sub> Antagonists by Michael A. Letavic, Brian Lord, François Bischoff, Natalie A. Hawryluk, Serge Pieters, Jason C. Rech, Zachary S. Sales, Adriana I. Velter, Hong Ao, Pascal Bonaventure, Víctor Contreras, Xiaohui Jiang, Kirsten L. Morton, Brian Scott, Qi Wang, Alan D. Wickenden, Nicholas I. Carruthers, Anindya Bhattacharya
Published 2013Artigo -
2
Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome by Oren Rom, Yuhao Liu, Zhipeng Liu, Ying Zhao, Jianfeng Wu, Alia Ghrayeb, Luis Villacorta, Yanbo Fan, Lin Chang, Lu Wang, Cai Liu, Dongshan Yang, Jun Song, Jason C. Rech, Yanhong Guo, Huilun Wang, Guizhen Zhao, Wenying Liang, Yui Koike, Haocheng Lu, Tomonari Koike, Tony Hayek, Subramaniam Pennathur, Chuanwu Xi, Bo Wen, Duxin Sun, Minerva T. Garcia-Barrio, Michael Aviram, Eyal Gottlieb, Inbal Mor, Wanqing Liu, Jifeng Zhang, Y. Eugene Chen
Published 2020Artigo
Search Tools:
Related Subjects
Biochemistry
Biology
Chemistry
Internal medicine
Medicine
Pharmacology
Amino acid
Beta oxidation
Bioinformatics
Blockade
Disease
Enzyme
Fatty acid
Fatty liver
Glutathione
Glycine
Gut flora
Gut microbiome
Human brain
In vitro
Inflammation
Leucine
Lipogenesis
Metabolism
Microbiome
Neuroscience
Nonalcoholic fatty liver disease
Potency
Receptor
Tripeptide